VREALFUN-TBI: Virtual Reality in Rehabilitation of Executive Functions in Children With Mild or Moderate Traumatic Brain Injury

Sponsor
Merja Nikula (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06127459
Collaborator
University of Oulu (Other), Aalto University (Other), University of Helsinki (Other), Helsinki University Central Hospital (Other)
44
1
2
35.9
1.2

Study Details

Study Description

Brief Summary

Traumatic brain injury (TBI) causes lifelong disability. Children with TBI often have difficulties in attention regulation and executive functions affecting their daily living. Need for rehabilitation is often long-lasting and there is an increasing demand for timely, cost-effective, and feasible rehabilitation methods, where the training is targeted to support daily life functional capacity. The use of Virtual Reality (VR) in the rehabilitation of children with attention and executive function deficits offers opportunities to practice skills required in everyday life in environments emulating real-life situations.

The aim of this research project is to develop a novel effective VR rehabilitation method for children with deficits in attention, activity control, and executive functions by using a virtual environment that corresponds to typical everyday life. In this randomized control study, VR glasses are used to present the tasks, and the levels of difficulty are adjusted according to the child's progress.

The researchers expect that; 1) Intensive training improves the attention regulation, activity control skills, and executive functions of the children in the intervention group 2)Training of executive skills with motivating tasks in a virtual environment that is built to meet challenging everyday situations transfers to the child's everyday life, 3)The duration of the training effect does not depend on the success of the VR training itself, but on how well the child adopts new strategies that make everyday life easier and how the parent is able to support the child's positive behaviour in everyday life.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Parental Guidance
  • Behavioral: Virtual Reality Game
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Virtual Reality in Rehabilitation of Executive Functions in Children (VREALFUN)
Anticipated Study Start Date :
Jan 2, 2024
Anticipated Primary Completion Date :
Dec 31, 2026
Anticipated Study Completion Date :
Dec 31, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Parental Guidance+Virtual Reality Game

Behavioral: Parental Guidance
Parents get guidance for children's positive behaviour support by using parts of Self-Help Program on the MentalHub.fi (in Finnish: Mielenterveystalo.fi) website regarding children's challenging behaviour (in Finnish: Lasten haastavan käytöksen omahoito-ohjelma).
Other Names:
  • Self-Help Program of children's challenging behaviour ( Program name in Finnish: Lasten haastavan käytöksen omahoito-ohjelma).
  • Behavioral: Virtual Reality Game
    Virtual reality game for rehabilitation of attention, activity control and executive functions by using the virtual environment that corresponds to the typical everyday situations at home.

    No Intervention: Control Group

    This group implement the rehabilitation plan drawn up in specialized medical care (treatment as usual).

    Outcome Measures

    Primary Outcome Measures

    1. Epeli (Executive Performance in Everyday LIving) task [Baseline, 4-6 weeks, 6 months and 12 months.]

      A virtual reality task for attention, executive function, and prospective memory. Change in total score, task efficacy, navigation efficacy, controller motion, and total action.

    2. ADHD-rating scale IV (ADHD-RS) (parent report) [Baseline, 4-6 weeks, 6 months and 12 months.]

      The ADHD-RS (parent report) is an assessment of a child's ADHD symptoms with 18 items based on the child's behaviour over the past 6 months. 4-point Likert scale. The total score ranges 0-54, scores in inattention subscale and hyperactivity/impulsivity subscale range 0-27. Change in the total score, inattention subscale score, and hyperactivity/impulsivity subscale score on a parent-rated ADHD-RS. A lower score means a better outcome.

    3. Epeli Questionnaire (parent report) [Baseline, 4-6 weeks, 6 months and 12 months.]

      An assessment of a child's functional ability and the amount of positive feedback given by the parent to the child over the past 4 weeks. 5-point Likert scale. 2 subscales: Functional ability subscale where score ranges 4-20, and Positive feedback subscale where score ranges 4-20. Change in Functional ability subscale score and Positive feedback subscale score on parent-rated Epeli- questionnaire. A higher score means a better outcome.

    4. Epeli Questionnaire (child report) [Baseline, 4-6 weeks, 6 months and 12 months.]

      An assessment of a child's functional ability and the amount of positive feedback given by the parent to the child over the past 4 weeks. 5-point Likert scale. 2 subscales: Functional ability subscale where score ranges 4-20, and Positive feedback subscale where score ranges 4-20. Change in Functional ability subscale score and Positive feedback subscale score on child-rated Epeli- questionnaire. A higher score means a better outcome.

    Secondary Outcome Measures

    1. Behavior Rating Inventory of Executive Function (BRIEF-2) (parent form) [Baseline, 4-6 weeks, 6 months and 12 months.]

      A measure of executive functions of children and adolescents in natural settings containing 63 items rated by the parent. 3-point Likert scale. Change in Global Executive Composite score, Behavior regulation score, Emotion regulation score, and Cognitive regulation score on parent-rated BRIEF-2. In case the data in the Behavior regulation, Emotion regulation, and Cognitive regulation subscales are not too strongly correlated (r<0.7) and there will be a significant effect of the intervention on the BRIEF-2 Global Executive Composite score, we will use the subscales to conduct a post hoc analysis examining which domains of executive functions are affected. A higher score means a worse outcome.

    2. Behavior Rating Inventory of Executive Function (BRIEF-2) (teacher form) [Baseline, 4-6 weeks, 6 months and 12 months.]

      A measure of executive functions of children and adolescents in natural settings containing 63 items rated by the teacher. 3-point Likert scale. Change in Global Executive Composite score, Behavior regulation score, Emotion regulation score, and Cognitive regulation score on teacher-rated BRIEF-2. In case the data in the Behavior regulation, Emotion regulation, and Cognitive regulation subscales are not too strongly correlated (r<0.7) and there will be a significant effect of the intervention on the BRIEF-2 Global Executive Composite score, we will use the subscales to conduct a post hoc analysis examining which domains of executive functions are affected. A higher score means a worse outcome.

    3. Concentration questionnaire (in Finnish: Keskittymiskysely) [Baseline, 4-6 weeks, 6 months and 12 months.]

      An assessment of attention and executive function difficulties in school-aged children with 55 items. 3-point Likert Scale, Total score range 0-110. Change in Total score, Distractibility score (range 0-8), sum of Impulsivity and Motor hyperactivity subscales scores (range 0-32), sum of Directing, Sustaining and Shifting Attention subscales scores (range 0-30), and sum of Initiative, Planning, Execution and Evaluation of Action subscales scores (range 0-40) on teacher-rated Concentration questionnaire. In case the data in the Distractibility subscale, Impulsivity and Motor hyperactivity subscales, Attention subscales and Executive subscales are not too strongly correlated (r<0.7) and there will be a significant effect of the intervention on Concentration questionnaire Total score, we will use the subscales to conduct a post hoc analysis examining which domains of executive functions are affected. A higher score implies a worse outcome.

    4. Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents Revised Version ( KINDL-R) (parent version) [Baseline, 4-6 weeks, 6 months and 12 months.]

      An assessment of Health-Related Quality of Life in children and adolescents with 24 items. 5-point Likert scale. Change in Total score on parent-rated questionnaire. A higher score means a better outcome.

    5. 9. Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents Revised Version (KINDL-R) (self-report version) [Baseline, 4-6 weeks, 6 months and 12 months.]

      An assessment of Health-Related Quality of Life in children and adolescents with 24 items. 5-point Likert scale. Change in Total score on child-rated questionnaire. A higher score means a better outcome.

    6. N-back test [Baseline, 4-6 weeks, 6 months and 12 months.]

      A test for a working memory. Change in 2-back and 1-back hitrate and reaction time.

    7. The Conners Continuous Performance Test 3rd Edition (Conners CPT3) [Baseline, 4-6 weeks, 6 months and 12 months.]

      A computerized attention task validated in individuals aged 8 years and older. Change in scores on Conners Continuous Performance Test (CPT-3).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    8 Years to 12 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Mild to moderate traumatic brain injury (ICD-10: S06.0-S06.6 and S06.8-S06.9 and criteria defined in the Current Care Recommendation, 2021) and

    • The challenges of attention and executive function identified in the assessment of a neuropsychologist/experienced psychologist and

    • Age 8-12 years and

    • Finnish as a native language

    Exclusion Criteria:
    • Sensitivity to flashing light,

    • Epilepsy (ICD-10 G40),

    • Mental retardation (ICD-10 F70-F79),

    • Pervasive developmental disorders (ICD-10 F84),

    • Inflammatory diseases of the central nervous system (ICD-10 G00-G09),

    • Severe cerebral palsy syndrome (ICD-10 G80, GMFCS 4-5, MACS 3-5),

    • Brain tumour, and

    • Multiple pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Oulu University Hospital Oulu Finland 90029

    Sponsors and Collaborators

    • Merja Nikula
    • University of Oulu
    • Aalto University
    • University of Helsinki
    • Helsinki University Central Hospital

    Investigators

    • Study Chair: Johanna Uusimaa, MD, PhD, Oulu University Hospital
    • Principal Investigator: Merja Nikula, M.Psych., Oulu University Hospital
    • Study Director: Mirjami Mäntymaa, MD, PhD, Oulu University Hospital
    • Study Director: Juha Salmitaival, PhD, Aalto University, Finland

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Merja Nikula, Principal investigator, Oulu University Hospital
    ClinicalTrials.gov Identifier:
    NCT06127459
    Other Study ID Numbers:
    • 206/ 2021
    First Posted:
    Nov 13, 2023
    Last Update Posted:
    Nov 13, 2023
    Last Verified:
    Nov 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Merja Nikula, Principal investigator, Oulu University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 13, 2023